Evidence map›Paper›PMID 40419781›Full record

SynthesisEvidence-based dentistry2025

Surgical periodontal therapy for the management of intrabony/furcation defects with and without topically delivered Alendronate - a systematic review and meta-analysis.

A Rizwan Ali, Arun Kumar Patnana, Pravin Kumar, Karishma Pathak, Ankita Chugh, Kirti Chaudhry

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Evidence-based dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A Rizwan AliDepartment Of Dentistry, All India Institute Of Medical Sciences, Jodhpur, India. rizu241194@gmail.com.ORCID http://orcid.org/0000-0003-3523-9655
Arun Kumar PatnanaDepartment Of Dentistry, All India Institute Of Medical Sciences, Rajkot, India.
Pravin KumarDepartment Of Dentistry, All India Institute Of Medical Sciences, Jodhpur, India.
Karishma PathakDepartment Of Dentistry, All India Institute Of Medical Sciences, Jodhpur, India.
Ankita ChughDepartment Of Dentistry, All India Institute Of Medical Sciences, Jodhpur, India.
Kirti ChaudhryDepartment Of Dentistry, All India Institute Of Medical Sciences, Jodhpur, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlendronate (ALN) are pyrophosphates which prevent bone resorption and aid in periodontal regeneration. The present review aimed to evaluate the success of surgical periodontal therapy in the management of intrabony/ furcation defects with and without topical application of ALN.

methodUsing combinations of different search terms, the authors searched the standard electronic databases for randomised controlled trials. Version 2 of the Cochrane risk of bias tool for randomised trials was used for quality appraisal. The random-effects model was used for the statistical analysis of estimated effect sizes. The overall quality of evidence was assessed using GRADEpro GDT software.

resultsNine studies satisfying all inclusion criteria were selected for qualitative analysis, and six studies with homogeneous data were selected for quantitative analysis. The overall risk of bias had "low" concerns in one study, "some" concerns in four studies, and "high" concerns in four studies. The pooled analysis showed that the experimental group showed a significant reduction in periodontal probing depth(PPD) and defect depth(DD) with a standard mean difference(SDM) of 1.06 mm (95% CI, 0.77-1.34; P < 0.00001; I

conclusionsThe topical application of ALN has been shown to enhance the effectiveness of surgical periodontal therapy by reducing the PPD and DD and increasing the CAL; however, the certainty of evidence remains very low to low.

Indexed as

AlendronateAlveolar Bone LossBone Density Conservation AgentsFurcation DefectsAdministration, TopicalHumansAlendronateBone Density Conservation Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.